1 / 1
Dacomitinib(Vizimpro)
Acetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine Injection
Reference price:
Manufacturer:
Pfizer Inc.
Formulation:
TABLET
Validity period:
24 months
Reminder: The outer packaging is for reference only, please purchase and use under the guidance of a pharmacist. For read by medical and pharmaceutical professionals only.

Generic name

Dacomitinib(Vizimpro)
English name
Dacomitinib
Alternative Names
Vizimpro
Drug prices
Indications

VIZIMPRO is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21 L858R substitution mutations, as detected by an FDA-approved test.

Therapeutic Target
EGFR+EGFRL858R+EGFR-Ex19del+HER2+HER4
Active Ingredients
Dacomitinib
Dosage form
TABLET
specifications
45mg * 30 tablets/box
Description
Dosage and Administration

The recommended dosage is 45 mg taken orally once daily, with or without food. Treatment should continue until disease progression or unacceptable toxicity occurs. Dose reductions to 30 mg and then to 15 mg are recommended for management of specific adverse reactions. Avoid concomitant use with proton pump inhibitors (PPIs).

CATEGORY NAVIGATION
RECOMMENDED ARTICLES
RELATED ARTICLES
Precautions for Dacomitinib

It is of great importance for both patients and doctors to understand the precautions before using dacomitinib...

Monday, September 8th, 2025, 17:01
Dacomitinib: Clinical Uses, Recommended Dosage, Potential Side Effects

Dacomitinib is an oral tyrosine kinase inhibitor primarily used as a first-line treatment for patients with...

Monday, September 8th, 2025, 16:56
How to Buy Dacomitinib at a Lower Cost

Dacomitinib, with the English name Dacomitinib, is originally developed by Pfizer Inc. of the United States. It is a...

Monday, September 8th, 2025, 16:44
What is the Price of Dacomitinib?

Dacomitinib is a second-generation, irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor...

Monday, September 8th, 2025, 16:36
What Are the Purchase Channels for Dacomitinib?

Dacomitinib is a second-generation EGFR tyrosine kinase inhibitor, which has been approved in China for the...

Monday, September 8th, 2025, 16:32
What Are the Purchasing Channels for Dacomitinib?

Dacomitinib, also known by other names such as Vizimpro, Dacoplice, is mainly used for the treatment of metastatic...

Monday, September 8th, 2025, 16:28
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved